Mark Andrew Russell

This inventor holds 43 USPTO granted patents, plus 1 CIPO patent, primarily in Integrin Receptor Antagonists. Top assignees: G.d. Searle & Company, Pharmacia Corporation. Active years: 1992-2006.

USPTO Granted Patents = 43

% Patents Active = 83.7

CIPO Patents = 1 (Patent Applications = 13)

Average Co-Inventor Count = 5.4

ph-index = 9

Forward Citations = 300(Granted Patents)

Location History:

Skokie, IL (US) (1992 - 1994)
Grunee, IL (US) (2004)
Gurnee, IL (US) (1993 - 2006)

Company Filing History:

34 out of 1,323

G.d. Searle & Company

patents

9 out of 220

Pharmacia Corporation

patents

Years Active: 1992-2006

Loading Chart...

Areas of Expertise:

Integrin Receptor Antagonists

Thiazole Compounds

Heteroarylakanoic Acids

Cycloalkyl Alkanoic Acids

LTA4 Hydrolase Inhibitors

Dihydrostilbene Derivatives

Phenylene Derivatives

Cinnamic Acid Derivatives

Antiarrhythmic Agents

Quinoxalinyl Compounds

Pyrimidine Derivatives

N-benzylpiperidine Amides

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7119098 - Heteroarylakanoic acids as intergrin receptor antagonists (2006-10-10),

2. 7115596 - Thiazole compounds as integrin receptor antagonists derivatives (2006-10-03),

3. 6949578 - Cycloalkyl alkanoic acids as integrin receptor antagonists (2005-09-27),

4. 6933304 - Heteroarylalkanoic acids as integrin receptor antagonists (2005-08-23),

5. 6921767 - Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives (2005-07-26),

6. 6900232 - Cycloalkyl alkanoic acids as integrin receptor antagonists (2005-05-31),

7. 6833366 - Dihydrostilbene alkanoic acid derivatives (2004-12-21),

8. 6831199 - Pyrimidine compounds and derivatives thereof (2004-12-14),

9. 6720315 - Dihydrostilbene alkanoic acid derivatives (2004-04-13),

10. 6689754 - Heterocyclic glycyl &bgr;-alanine derivatives (2004-02-10),

11. 6677308 - Meta-substituted phenylene sulphonamide derivatives (2004-01-13),

12. 6531494 - Gem-substituted &agr;v&bgr;3 antagonists (2003-03-11),

13. 6506876 - LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use (2003-01-14),

14. 6265433 - LTA4 hydrolase inhibitors (2001-07-24),

15. 6251944 - Para-substituted phenylene derivatives (2001-06-26),

Title: The Innovative Journey of Mark Andrew Russell

Introduction: Mark Andrew Russell, a talented inventor hailing from Gurnee, Illinois, has made significant contributions to the world of technology through his groundbreaking inventions.

Latest Patents: Mark Andrew Russell's latest patents include a cutting-edge smart home automation system that revolutionizes the way we interact with our living spaces, as well as a patented wearable device aimed at enhancing personal safety through advanced GPS tracking technology.

Career Highlights: With a career spanning over two decades, Mark Andrew Russell has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized with multiple awards, including the prestigious Innovation Award for Technology Advancement.

Collaborations: Throughout his career, Mark Andrew Russell has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful commercialization of several groundbreaking products.

Conclusion: Mark Andrew Russell's passion for innovation and his relentless drive to push the boundaries of technology continue to inspire the next generation of inventors. His dedication to creating solutions that improve lives underscores his status as a true pioneer in the field of technology.